IntegraGen Competitors and Similar CompaniesClear all
IntegraGen's competitors and similar companies include Opko Health and MorphoSys.
 IntegraGen IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases. |  Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. |  MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. | |
Founding Date | Founding Date 2000 | Founding Date 2007 | Founding Date 1992 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Évry, FR HQ Cambridge, US | Locations Miami, US HQ Woburn, US | Locations Planegg, DE HQ Boston, US |
Employees | Employees 4420% decrease | Employees 6,0967% increase | Employees 464 |
Valuation ($) | Valuation ($) 3.8 m | Valuation ($) 1.1 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €5m (FY, 2025) | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) €238.3m (FY, 2023) |
Cost of goods | Cost of goods €1.8m (FY, 2025) | Cost of goods $400.9m (FY, 2025) | Cost of goods €34.6m (FY, 2023) |
Gross profit | Gross profit €3.5m (FY, 2025) | Gross profit $205.9m (FY, 2025) | Gross profit €205.5m (FY, 2023) |
Net income | Net income (€2.7m) (FY, 2025) | Net income ($225.7m) (FY, 2025) | Net income (€189.7m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 14.3m | Total funding raised $ 31m | Total funding raised $ 126m |
For sources of this data, please see the company profile
View Company Profiles
Opko Health
HQ
Miami, US
Employees
6,096↑ 7% increase
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View companyMorphoSys
HQ
Planegg, DE
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
View company